🇺🇸 FDA
Patent

US 9650391

N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as Axl inhibitors

granted A61PA61P13/12A61P15/00

Quick answer

US patent 9650391 (N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as Axl inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P13/12, A61P15/00, A61P15/08, A61P17/06